These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24577320)

  • 1. Changes in intensity of serotonin syndrome caused by adverse interaction between monoamine oxidase inhibitors and serotonin reuptake blockers.
    Tao R; Rudacille M; Zhang G; Ma Z
    Neuropsychopharmacology; 2014 Jul; 39(8):1996-2007. PubMed ID: 24577320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of co-administration of a selective serotonin reuptake inhibitor and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
    Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
    Eur J Pharmacol; 2006 Feb; 532(3):258-64. PubMed ID: 16488409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of 5-hydroxytryptamine efflux in rat brain during a mild, moderate and severe serotonin-toxicity syndrome.
    Zhang G; Krishnamoorthy S; Ma Z; Vukovich NP; Huang X; Tao R
    Eur J Pharmacol; 2009 Aug; 615(1-3):66-75. PubMed ID: 19464285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of 5-HT2A receptors in the serotonin (5-HT) syndrome caused by excessive 5-HT efflux in rat brain.
    Krishnamoorthy S; Ma Z; Zhang G; Wei J; Auerbach SB; Tao R
    Basic Clin Pharmacol Toxicol; 2010 Oct; 107(4):830-41. PubMed ID: 20456331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of serotonin-toxicity syndrome (toxidrome) elicited by 5-hydroxy-l-tryptophan in clorgyline-pretreated rats.
    Ma Z; Zhang G; Jenney C; Krishnamoorthy S; Tao R
    Eur J Pharmacol; 2008 Jul; 588(2-3):198-206. PubMed ID: 18499101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone attenuates the increase of extracellular nitric oxide and glutamate levels in serotonin syndrome animal models.
    Shioda K; Nisijima K; Kasai M; Yoshino T; Kato S
    Neurosci Lett; 2012 Oct; 528(1):22-6. PubMed ID: 22985508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular serotonin, dopamine and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine.
    Shioda K; Nisijima K; Yoshino T; Kato S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):633-40. PubMed ID: 15276688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability.
    Zazpe A; Artaiz I; Labeaga L; Lucero ML; Orjales A
    Neuropharmacology; 2007 Mar; 52(3):975-84. PubMed ID: 17141811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of electroencephalographic and biochemical responses at 5-HT promoting drug-induced onset of serotonin syndrome in rats.
    Ma Z; Rudacille M; Prentice HM; Tao R
    J Neurochem; 2013 Jun; 125(5):774-89. PubMed ID: 23286698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
    Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
    Eur J Pharmacol; 2007 Jun; 565(1-3):105-12. PubMed ID: 17400208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
    Hewton R; Salem A; Irvine RJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylene blue and serotonin toxicity: definite causal link.
    Gillman PK
    Psychosomatics; 2010; 51(5):448-9. PubMed ID: 20833947
    [No Abstract]   [Full Text] [Related]  

  • 13. 5-HT reuptake and 5-HT2 receptors modulate capsaicin-evoked hypothermia in rats.
    Ding Z; Cowan A; Rawls SM
    Neurosci Lett; 2008 Jan; 430(3):191-6. PubMed ID: 18155835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of monoamine oxidase inhibition and monoamine depletion in fenfluramine-induced neurotoxicity and serotonin release.
    Halladay AK; Kirschner E; Hesse K; Fisher H; Wagner GC
    Pharmacol Toxicol; 2001 Nov; 89(5):237-48. PubMed ID: 11881977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term administration of monoamine oxidase inhibitors alters the firing rate and pattern of dopamine neurons in the ventral tegmental area.
    Chenu F; El Mansari M; Blier P
    Int J Neuropsychopharmacol; 2009 May; 12(4):475-85. PubMed ID: 18700056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats.
    Tao R; Shokry IM; Callanan JJ; Adams HD; Ma Z
    Psychopharmacology (Berl); 2015 Apr; 232(7):1245-60. PubMed ID: 25300903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T; Umbers V; Gartside SE
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.
    Halberstadt AL
    Pharmacol Biochem Behav; 2016 Apr; 143():1-10. PubMed ID: 26780349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT.
    Gartside SE; Umbers V; Hajós M; Sharp T
    Br J Pharmacol; 1995 Jul; 115(6):1064-70. PubMed ID: 7582504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.
    Halberstadt AL; Buell MR; Masten VL; Risbrough VB; Geyer MA
    Psychopharmacology (Berl); 2008 Nov; 201(1):55-66. PubMed ID: 18604652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.